Found 60 matching trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome PHASE2 The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects PHASE1 The primary objective of this study is to assess the pharmacodynamic (PD) e...
Show More Learn More & Join Trial
Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics) PHASE4 Rationale: the use of antiplatelet drugs (i.e. clopidogrel, ticagrelor or p...
Show More Learn More & Join Trial
VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study N/A The purpose of this study is to determine the range of expected PRUTest val...
Show More Location
Multiple Locations
Learn More & Join Trial
Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study. PHASE4 Oral antiplatelet therapy is a key treatment of the STEMI (ST elevation myo...
Show More Location
CHU de Bordeaux - Hôpital du Haut Lévèque
Learn More & Join Trial
SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy PHASE2 The purpose of this study is to see if one month of dual antiplatelet thera...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response PHASE4 The overall objective of this study is to assess P2Y12 inhibition ex vivo i...
Show More Location
Multiple Locations
Learn More & Join Trial
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort PHASE4 XIENCE V USA is a prospective, multi-center, multi-cohort postapproval stud...
Show More Location
Birmingham Heart Clinic, PC
Learn More & Join Trial
Platelet Reactivity After an Eastern Asian Loading Dose of Prasugrel in Taiwanese ACS Patients NA Prasugrel has a faster onset of action and greater platelet inhibition with...
Show More Location
Feng Yuan Hospital
Learn More & Join Trial
Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data N/A Investigators are building an empirical evidence base for real world data t...
Show More Location
Brigham And Women's Hospital
Learn More & Join Trial